The future of cancer care is contingent on better understanding of molecular, clinical, and outcome data. This can be achieved by leveraging collaborative affiliations and networks locally and internationally. Caris Precision Oncology Alliance (POA) is a vivid example of how this large network takes advantage of collaboration and understanding the nuances of molecular profiling to scale up the research operations that eventually can help all patients diagnosed with cancer. In this presentation, we will highlight how this large network operates and works together to advance the science forward.
Learning Objectives:
1. Classify the value of broad molecular profiling.
2. Express the value of large collaborative networks.
3. Evaluate the future of precision oncology.